Over the last decade, India’s pharmaceutical sector has transformed from a regional player into a cornerstone of the global drug supply chain. Known for its generics, contract manufacturing, and active pharmaceutical ingredients (APIs), India now plays a vital role in ensuring global access to affordable medicines. But what are the key factors fueling India’s rise?
In today’s fast-paced pharmaceutical industry, selecting the right contract manufacturing partner is one of the most critical strategic decisions for any pharma business. A strong partnership not only ensures high-quality production, but also impacts regulatory compliance, time-to-market, product portfolio growth, and ultimately, profitability. Whether you’re a startup planning your first drug, or an established company
The pharmaceutical industry is highly competitive and regulated, requiring companies to maintain high product quality while managing costs and ensuring timely market delivery. To overcome these challenges, many pharmaceutical companies turn to third-party contract manufacturing as a strategic solution. Contract manufacturing allows pharmaceutical companies to outsource the production of medicines to specialized manufacturers, enabling them
